These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7905149)

  • 21. Epstein-Barr virus infections and their association with human malignancies: some key questions.
    Griffin BE; Xue SA
    Ann Med; 1998 Jun; 30(3):249-59. PubMed ID: 9677010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus and epithelial cells: implications for the otolaryngologist.
    Clark DR; Young LS; Proops DW
    J Otolaryngol; 1988 Feb; 17(1):1-3. PubMed ID: 2830415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-correlation of in vivo and in vitro parameters of Epstein-Barr virus persistence suggests heterogeneity of B cell infection.
    Johannessen I; Haque T; N'Jie-Jobe J; Crawford DH
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1631-6. PubMed ID: 9680124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus detection by in situ hybridization in fine-needle aspiration biopsies.
    Pacchioni D; Negro F; Valente G; Bussolati G
    Diagn Mol Pathol; 1994 Jun; 3(2):100-4. PubMed ID: 8061887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus infection and the pathogenesis of malignant lymphomas.
    Niedobitek G; Young LS; Herbst H
    Cancer Surv; 1997; 30():143-62. PubMed ID: 9547991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biology of the Epstein-Barr virus].
    Morand P; Seigneurin JM
    Ann Biol Clin (Paris); 1989; 47(7):421-7. PubMed ID: 2554764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epstein-Barr virus infections. New pathogenic and clinical aspects].
    Wilmes E; Wolf H
    Laryngorhinootologie; 1989 Jan; 68(1):36-43. PubMed ID: 2536874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus and nasopharyngeal carcinoma.
    Young LS; Dawson CW
    Chin J Cancer; 2014 Dec; 33(12):581-90. PubMed ID: 25418193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus and carcinomas: rare association of the virus with gastric adenocarcinomas.
    Rowlands DC; Ito M; Mangham DC; Reynolds G; Herbst H; Hallissey MT; Fielding JW; Newbold KM; Jones EL; Young LS
    Br J Cancer; 1993 Nov; 68(5):1014-9. PubMed ID: 8217590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma.
    Niedobitek G; Agathanggelou A; Nicholls JM
    Semin Cancer Biol; 1996 Aug; 7(4):165-74. PubMed ID: 8946600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus and carcinomas.
    Niedobitek G; Herbst H; Young LS
    Int J Clin Lab Res; 1993; 23(1):17-24. PubMed ID: 8386567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous progressive multifocal leukoencephalopathy, Epstein-Barr virus (EBV) latent infection and cerebral parenchymal infiltration during chronic lymphocytic leukemia.
    Farge D; Hervé R; Mikol J; Sauvaget F; Ingrand D; Singer B; Ferchal F; Aupérin I; Gray F; Sudaka A
    Leukemia; 1994 Feb; 8(2):318-21. PubMed ID: 8309257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune surveillance against Epstein-Barr virus.
    Moss DJ; Burrows SR; Khanna R; Misko IS; Sculley TB
    Semin Immunol; 1992 Apr; 4(2):97-104. PubMed ID: 1377517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection.
    Barletta JM; Kingma DW; Ling Y; Charache P; Mann RB; Ambinder RF
    Mol Cell Probes; 1993 Apr; 7(2):105-9. PubMed ID: 8391639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secreted Oral Epithelial Cell Membrane Vesicles Induce Epstein-Barr Virus Reactivation in Latently Infected B Cells.
    Lin Z; Swan K; Zhang X; Cao S; Brett Z; Drury S; Strong MJ; Fewell C; Puetter A; Wang X; Ferris M; Sullivan DE; Li L; Flemington EK
    J Virol; 2016 Jan; 90(7):3469-79. PubMed ID: 26764001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus (EBV)-lymphoid cell interactions. I. Quantification of EBV particles required for the membrane immunofluorescence assay and the comparative expression of EBV receptors on different human B, T and null cell lines.
    Patel P; Menezes J
    J Gen Virol; 1981 Mar; 53(Pt 1):1-11. PubMed ID: 6268736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the topography of Epstein-Barr virus infection in human immunodeficiency virus-associated lymphoid tissues.
    Arber DA; Shibata D; Chen YY; Weiss LM
    Mod Pathol; 1992 Sep; 5(5):559-66. PubMed ID: 1344820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.
    Church TM; Verma D; Thompson J; Swaminathan S
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The biology of EBV infection in human epithelial cells.
    Tsao SW; Tsang CM; Pang PS; Zhang G; Chen H; Lo KW
    Semin Cancer Biol; 2012 Apr; 22(2):137-43. PubMed ID: 22497025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current Trends and Alternative Scenarios in EBV Research.
    Minarovits J; Niller HH
    Methods Mol Biol; 2017; 1532():1-32. PubMed ID: 27873264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.